Log In
BCIQ
Print this Print this
 

SP-420

  Manage Alerts
Collapse Summary General Information
Company Sideris Pharmaceuticals Inc.
DescriptionOral small molecule iron chelator
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationTransfusion
Indication DetailsTreat transfusional iron overload
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$300.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/28/2013

$300.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today